Protecting 340B Eligibility Through a Proactive DSH Strategy
For hospitals that rely on 340B savings to support patient care and community programs, maintaining eligibility should remain a strategic financial priority. A key factor in 340B eligibility is a hospital’s Disproportionate Share Hospital (DSH) percentage, which reflects the organization’s service to low-income patient populations. Hospitals operating near established eligibility thresholds should closely monitor their DSH performance, as even modest changes in payer mix, utilization patterns, or reporting accuracy can affect eligibility status.
The financial implications can be significant. Preserving or regaining 340B eligibility may represent millions of dollars in annual savings that can be reinvested into patient care, workforce initiatives, and community health programs. Yet many organizations focus primarily on Medicaid days when evaluating DSH performance, overlooking other important drivers within the calculation.
In addition to Medicaid utilization, total inpatient days and the Medicare Supplemental Security Income (SSI) ratio play a critical role in determining a hospital’s DSH percentage. Understanding how these components interact is essential for organizations seeking to strengthen their position and reduce the risk of falling below eligibility thresholds.
As healthcare organizations continue to navigate changes in Medicaid enrollment, reimbursement pressures, and evolving utilization patterns, now is an appropriate time to evaluate whether current DSH management processes are optimized. Hospitals should consider:
- Assessing the accuracy and completeness of DSH-related data and reporting.
- Identifying potential enrollment, eligibility, or documentation gaps that may impact results.
- Evaluating operational and financial strategies that could strengthen DSH performance over time.
- Prioritizing initiatives based on expected impact, implementation timelines, operational requirements, and return on investment.
Some opportunities may influence an upcoming cost report, while others require longer-term planning and cross-functional coordination. Taking a proactive approach allows organizations to better understand the factors driving their DSH percentage and make informed decisions before eligibility concerns arise.
Importantly, DSH performance should not be viewed solely as a reimbursement issue. Sustainable results often require collaboration across finance, reimbursement, revenue cycle, patient access, case management, and operational leadership. By treating DSH strategy as an enterprise-wide priority, hospitals can improve visibility into key performance drivers and strengthen their long-term financial position.
For healthcare leaders, the message is clear: waiting until a cost report is filed—or until eligibility is at risk—can limit available options. A proactive assessment can help organizations identify opportunities, quantify potential financial impact, and develop a roadmap to support long-term 340B eligibility and financial sustainability.
How Alliant Can Help
Alliant’s healthcare consultants work alongside hospitals and health systems to evaluate DSH performance, identify opportunities for improvement, and develop practical strategies aligned with organizational goals. Through data-driven analysis and collaborative planning, we help healthcare leaders better understand the factors influencing DSH eligibility and position their organizations for long-term success.